Cidara Therapeutics Inc buy melinda
Start price
21.03.18
/
50%
€5.01
Target price
21.09.18
€7.31
Performance (%)
-25.23%
End price
21.09.18
€3.74
Summary
This prediction ended on 21.09.18 with a price of €3.74. The prediction for Cidara Therapeutics Inc disappointed with a performance of -25.23%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cidara Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
Comments by melinda for this prediction
In the thread Cidara Therapeutics Inc diskutieren
Biotechnologie und medizinische SecteurRecherche
Cidara Therapeutics, Inc.
Cidara Therapeutics stellt aktualisierte klinische Daten für seine Anti - Pilz - Blei rézafungine
(Laufzeit überschritten)
Stopped prediction by melinda for Cidara Therapeutics Inc
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€2.41
31.03.19
31.03.19
€2.71
04.11.21
04.11.21
-31.57%
22.06.21
22.06.21
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€9.59
19.03.16
19.03.16
€13.53
13.04.16
13.04.16
41.58%
13.04.16
13.04.16